BUDGET IMPACT FOR OLAPARIB MAINTENANCE THERAPY FOR BRCA-MUTATED PLATINUM SENSITIVE RECURRENT OVARIAN CANCER IN PANAMA

被引:0
|
作者
Torres Toala, F. G. [1 ]
Solorzano, J. [2 ]
Baldi, J. [2 ]
Castillo-Fernandez, O. [3 ]
机构
[1] Makroscopio, Quito, Ecuador
[2] AstraZeneca CAMCAR MAC, San Jose, Costa Rica
[3] Inst Oncol Nacl, Panama City, Panama
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN56
引用
收藏
页码:S22 / S22
页数:1
相关论文
共 50 条
  • [21] Maintenance olaparib in Asian patients with germline BRCA-mutated metastatic pancreatic cancer
    Oh, Do-Youn
    Park, Joon Oh
    Kindler, Hedy L.
    Hammel, Pascal
    Reni, Michele
    Van Cutsem, Eric
    Macarulla, Teresa
    Hall, Michael J.
    Arnold, Dirk
    Reinacker-Schick, Anke
    Tortora, Giampaolo
    Algul, Hana
    O'Reilly, Eileen M.
    McGuiness, David
    Liu, Yu-Zhen
    Cui, Karen
    Schlienger, Katia
    Locker, Gershon Y.
    Golan, Talia
    ANNALS OF ONCOLOGY, 2021, 32 : S319 - S319
  • [22] MAINTENANCE OLAPARIB FOR BRCA-MUTATED OVARIAN CANCER (OC) PATIENTS IN 1ST LINE AND PLATINUM-SENSITIVE RELAPSED (PSR) SETTINGS: MAXIMIZING TREATMENT OPPORTUNITIES
    Poveda, A.
    Sackeyfio, A.
    Friedlander, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A133 - A133
  • [23] Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
    Ledermann, Jonathan
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon
    Scott, Clare
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Macpherson, Euan
    Watkins, Claire
    Carmichael, James
    Matulonis, Ursula
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15): : 1382 - 1392
  • [24] Adjuvant Olaparib in BRCA-Mutated Breast Cancer REPLY
    Tutt, Andrew N. J.
    Garber, Judy E.
    Geyer, Charles E., Jr.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (15): : 1440 - 1440
  • [25] Progress in BRCA-Mutated Ovarian Cancer
    Spriggs, David R.
    Longo, Dan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (26): : 2567 - 2568
  • [26] Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
    Wu, Bin
    Shi, Lizheng
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (11): : 1528 - +
  • [27] REAL WORLD OUTCOMES OF OLAPARIB MAINTENANCE THERAPY IN PATIENTS WITH BRCA1/2-MUTATED PLATINUM-SENSITIVE EPITHELIAL OVARIAN CANCER
    McLaren, A.
    White, M.
    Cartwright, D.
    Brown, J.
    Randhawa, M.
    Roxburgh, T.
    Glasspool, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A166 - A166
  • [28] MAINTENANCE TREATMENT WITH OLAPARIB IN BRCA-MUTATED HIGH GRADE SEROUS OVARIAN CANCER (HGSOC): OUR EXPERIENCE IN A CASE REPORT
    Mainella, A.
    Giacomi, N.
    Marmissolle, F.
    Vigo, S.
    Price, P.
    Sansano, M.
    Lujan, M. L.
    Zapata Caamano, G.
    Dominguez, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1585 - 1585
  • [29] COST-EFFECTIVENESS OF OLAPARIB AS A MAINTENANCE TREATMENT OPTION FOR NEWLY DIAGNOSED BRCA-MUTATED OVARIAN CANCER WHO ARE IN RESPONSE AFTER FIRST-LINE PLATINUM-BASED CHEMOTHERAPY IN PANAMA
    Castillo-Fernandez, O.
    Murtiera, S.
    Solorzano, J.
    Martin, C.
    Amador Sosa, J. L.
    Lim Law, M.
    Veliz Centella, I
    Cercone, J.
    Leon, A.
    VALUE IN HEALTH, 2020, 23 : S38 - S38
  • [30] Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer REPLY
    Robson, Mark
    Goessl, Carsten
    Domchek, Susan
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (18): : 1792 - 1793